BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 29181640)

  • 1. Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs.
    Noh K; Kang YR; Nepal MR; Shakya R; Kang MJ; Kang W; Lee S; Jeong HG; Jeong TC
    Arch Pharm Res; 2017 Dec; 40(12):1345-1355. PubMed ID: 29181640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human gut microbiota plays a role in the metabolism of drugs.
    Jourova L; Anzenbacher P; Anzenbacherova E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):317-26. PubMed ID: 27485182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of gut microbiota on drug metabolism and toxicity.
    Li H; He J; Jia W
    Expert Opin Drug Metab Toxicol; 2016; 12(1):31-40. PubMed ID: 26569070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?
    Swanson HI
    Drug Metab Dispos; 2015 Oct; 43(10):1499-504. PubMed ID: 26261284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omics for Understanding the Gut-Liver-Microbiome Axis and Precision Medicine.
    Khalsa J; Duffy LC; Riscuta G; Starke-Reed P; Hubbard VS
    Clin Pharmacol Drug Dev; 2017 Mar; 6(2):176-185. PubMed ID: 28263462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Gut Microbiota-Mediated Bile Acid Metabolism on the Solubilization Capacity of Bile Salt Micelles and Drug Solubility.
    Enright EF; Joyce SA; Gahan CG; Griffin BT
    Mol Pharm; 2017 Apr; 14(4):1251-1263. PubMed ID: 28186768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota-Mediated Drug-Antibiotic Interactions.
    Kim DH
    Drug Metab Dispos; 2015 Oct; 43(10):1581-9. PubMed ID: 25926432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of gut microbiota on drug metabolism.
    Kang MJ; Kim HG; Kim JS; Oh DG; Um YJ; Seo CS; Han JW; Cho HJ; Kim GH; Jeong TC; Jeong HG
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1295-308. PubMed ID: 24033282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Influence of Intestinal Tract and Probiotics on the Fate of Orally Administered Drugs.
    Stojančević M; Bojić G; Salami HA; Mikov M
    Curr Issues Mol Biol; 2014; 16():55-68. PubMed ID: 24002548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
    Chen F; Wen Q; Jiang J; Li HL; Tan YF; Li YH; Zeng NK
    J Ethnopharmacol; 2016 Feb; 179():253-64. PubMed ID: 26723469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical transformation of xenobiotics by the human gut microbiota.
    Koppel N; Maini Rekdal V; Balskus EP
    Science; 2017 Jun; 356(6344):. PubMed ID: 28642381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids.
    Klaassen CD; Cui JY
    Drug Metab Dispos; 2015 Oct; 43(10):1505-21. PubMed ID: 26261286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
    Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
    World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota changes and chronic hepatitis C virus infection.
    Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
    Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease.
    Prokopienko AJ; Nolin TD
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):71-82. PubMed ID: 28905671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of Host-Gut Microbiota Modulation of Therapeutic Outcome.
    Yip LY; Chan EC
    Drug Metab Dispos; 2015 Oct; 43(10):1619-31. PubMed ID: 25979259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of drugs and other xenobiotics in the gut lumen and wall.
    Ilett KF; Tee LB; Reeves PT; Minchin RF
    Pharmacol Ther; 1990; 46(1):67-93. PubMed ID: 2181492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alteration of intestinal permeability: the missing link between gut microbiota modifications and inflammation in obesity?].
    Genser L; Poitou C; Brot-Laroche É; Rousset M; Vaillant JC; Clément K; Thenet S; Leturque A
    Med Sci (Paris); 2016 May; 32(5):461-9. PubMed ID: 27225918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity.
    Cario E
    Curr Opin Support Palliat Care; 2016 Jun; 10(2):157-64. PubMed ID: 26986508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiome interactions with drug metabolism, efficacy, and toxicity.
    Wilson ID; Nicholson JK
    Transl Res; 2017 Jan; 179():204-222. PubMed ID: 27591027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.